Advertisement

Picture [iito] No Tracking 650x80px
Document › Details

Biognosys AG. (1/3/12). "Press Release: Biognosys and ETH Zurich Receive CHF 1.5m Funding from CTI".

Region Region Switzerland
Organisations Organisation Biognosys AG
  Organisation 2 KTI Innovation Promotion Agency (CTI / KTI) (CH)
  Today Innosuisse (Swiss Innovation Agency, formerly KTI/CTI)
  Group Switzerland (govt)
Products Product HRM-MS technology (Hyper Reaction Monitoring)
  Product 2 proteomic technology
Index terms Index term Biognosys–Switzerland (govt): grant, 201201 grant CHF1.5m to Biognosys + Aebersold Group at ETH Zurich for developm of HRM-MS technology
  Index term 2 Biognosys–ETH Zürich: HRM-MS technology, 201201 collab development Aebersold group
Person Person Aebersold, Ruedi (ETH Zurich 2005c– Professor Systems Biology before Institute of Systems Biology Seattle)
     


The Swiss Commission for Technology and Innovation (CTI) has granted CHF 1.5m for a research collaboration between Biognosys and the group of Prof. Aebersold, ETH Zurich, to bring the novel HRM-MS technology to the market.

Hyper Reaction Monitoring (HRM) is the next generation proteomics technology based on data independent acquisition (e.g. SWATH) that enables simultaneous measurement of 1000s of known and unknown proteins in a sample and subsequent extraction of protein profile data. Moreover, proteins in a sample measured with HRM can be easily analyzed retrospectively, including proteins that were not known or not considered relevant at the time of sample measurement. This innovative concept of "digital bio-banking" can potentially revolutionize clinical research and diagnostic. Biognosys has already achieved substantial advances in the development of HRM and now with the CTI support and in collaboration with EHT Zurich plans to bring the technology to the market.

With HRM Biognosys aims to provide consumers with a personal protein passport that contains snapshots of blood proteins tracked over a life-time. Such a digital protein passport, serving as a lifelong history of one`s own protein profile, is a powerful tool to monitor health / detect onset of diseases, and to preserve information for future advances in diagnostics and treatment.

   
Record changed: 2012-12-09

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Biognosys AG


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81




» top